Detalles de la búsqueda
1.
Safety and immunogenicity of rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine against SARS-CoV-2 in healthy adolescents: an open-label, non-randomized, multicenter, phase 1/2, dose-escalation study.
Front Immunol
; 14: 1228461, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37600800
2.
Immunogenicity and protectivity of intranasally delivered vector-based heterologous prime-boost COVID-19 vaccine Sputnik V in mice and non-human primates.
Emerg Microbes Infect
; 11(1): 2229-2247, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36031930
Resultados
1 -
2
de 2
1
Próxima >
>>